The FY20 MRP TSA supports hypothesis-driven studies to tackle the overarching FY20 MRP Challenge Statement and FY20 MRP Focus Areas. The TSA is intended to advance studies in melanoma through a multidisciplinary team, bringing together disciplines to foster a novel approach to melanoma research. The TSA requires that investigators jointly design a single project. However, each partner will be recognized as a Principal Investigator (PI), must submit a separate application, and will be the named PI on an individual award. The application must clearly define the synergistic components that will facilitate and accelerate progress in melanoma in a way that could not be accomplished through independent efforts. Each team member should offer unique skill sets and offer different perspectives on the project. Research projects funded by the TSA should address critical knowledge gaps with the FY20 MRP Challenge Statement covering at least one of the required FY20 MRP Focus Areas.
Brief Description